EUVIMED · CrossrefZeitschrift
Drug Resistance Updates
ISSN 1368-7646 · Elsevier BV
Neueste Artikel
Single-cell and spatial analysis of inflammation-associated resistance in intrahepatic cholangiocarcinoma
PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma
Drug resistance mechanisms and sensitization strategies in central nervous system tumors
Calibrating public genome archives for AMR surveillance: Four decades of redundancy-aware phylogenomics of pandemic Escherichia coli ST131
Macrophage-centered resistance programs in cancer: A unified framework for therapeutic resistance and precision immunotherapy
ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma
Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies
Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo
One Health genomic surveillance reveals transmission networks, resistance profiles and dissemination patterns of carbapenem-resistant Acinetobacter baumannii
Fit-for-purpose 3D cancer models for therapy resistance research: an evidence framework from observation to causation
A Th17-centered immune network for tertiary lymphoid structure formation in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
CARM1 orchestrates hypoxia-mediated chemoresistance through the H3R17me2a/FUS upregulation in colorectal cancer
Prophages at the Interface of Antibiotic Tolerance, Persistence and Antibiotic Resistance: Evidence, Mechanisms and Therapeutic Limits
ER stress-induced chaperone-assisted selective autophagy confers resistance to mitotic catastrophe-driven anticancer effects by degrading toxic protein aggregates to inhibit caspase-2 activation
Corrigendum to “RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress” [Drug Resist. Updat. 86 (2026) 101375]
Adaptive lineage plasticity drives multidrug resistance to KRAS-EGFR targeted therapy
The RELA-FTH1 axis in senescent cancer-associated fibroblasts creates a stromal iron sink that drives ferroptosis resistance and therapy failure across solid malignant tumors
Stepwise KPC mutational accumulation confers high-level ceftazidime–avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae
Effectiveness of Sulbactam/Durlobactam in carbapenem-resistant Acinetobacter baumannii pulmonary infection complicated with carbapenem-resistant Enterobacterales and/or carbapenem-resistant Pseudomonas aeruginosa infection: A prospective, multicenter, cohort study
Population genomics uncovers global distribution, antimicrobial resistance, and virulence factors of Streptococcus suis
Phage-essential oil synergy as an evolutionary and biophysical strategy against antimicrobial resistance
Liposomes containing histidine overcome poly ADP-ribose polymerase inhibitor resistance
Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy
NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma
Autophagy in thyroid cancer: Immune suppression and drug resistance
Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability
Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression
Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling
Mechanistic analysis on epigenetic programming of tumor drug resistance
Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy
EUVIMED